One of the challenges with the sperm DNA fragmentation results is the inconsistency and the large variability in the results obtained by different techniques. The terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay quantifies the incorporation of fluoresceinated dUTP into single-and double-strand DNA breaks by labeling the 3 0 -OH terminal with TdT. The goal of this study was optimize the TUNEL protocol for assessment of sperm DNA fragmentation by standardization of the method and comparison of the data across two reference laboratories (i) at Basel, Switzerland and (ii) Cleveland Clinic, Ohio, USA. Semen samples from 31 subjects grouped into three cohorts. Sperm DNA fragmentation was data measured by two experienced operators at two different laboratories using identical semen samples, assay kit, protocol and acquisition settings using identical flow cytometers (BD ACCURI C6). No significant differences were observed between the duplicates in any of the experiments performed. By including an additional washing step after fixation in paraformaldehyde, a high correlation was seen between the two laboratories (r = 0.94). A strong positive correlation was observed between the average sperm DNA fragmentation rates (r = 0.719). The mean sperm DNA fragmentation measured in each laboratory was similar. Both flow cytometers were identical in their settings and performance. This inter-and intra-laboratory study establishes that TUNEL is a reproducible assay when utilizing a standardized staining protocol and flow cytometer acquisition settings. Standardization and consensual guidelines for TUNEL validate the assay and establishes TUNEL as a robust test for measuring sperm DNA fragmentation especially in a multicenter setting.
INTRODUCTION
One of every six couples has to go through the ordeal of infertility within 1 year of attempting to conceive (ASRM: Practice Committee of American Society for Reproductive Medicine, 2013; Louis et al., 2013) . Male factor infertility is attributed to be the sole causative factor in 30% of infertile couples with an additional 50% attributed to both male as well as female factors (Anderson et al., 2009; Winters & Walsh, 2014) . Semen analysis remains a standard test at the core of male infertility evaluation. However, the classic semen parameters are not the best predictors of male fertility (Keel, 2006) . The predictive significance of routine semen parameters, that is sperm count, motility and normal morphology is low as these tests have inherent problems such as high inter-observer and intra-observer variability (Alvarez et al., 2003) . Conventional semen parameters are also unable to characterize the functional aspects of spermatozoa, that is the integrity of sperm chromatin and their ability to fertilize (Zini et al., 2002) .
Sperm DNA fragmentation (SDF) defined as either singlestrand or double-strand breaks, is one of the major cause of male infertility. It has been linked to impaired fertilization, poor embryo quality, increased spontaneous abortion rates and reduced pregnancy rates after assisted reproduction (Henkel et al., 2003; Seli et al., 2004; Evenson, 2011; Robinson et al., 2012; Evenson et al., 1999) . Oligoasthenoteratozoospermia has been correlated with high levels of DNA fragmentation (Lopes et al., 1998; Virro et al., 2004; Borini et al., 2006; Nijs et al., 2009) . Men with normal semen parameters have been shown to have variable levels of DNA fragmentation (Simon et al., 2011a, b) . Several studies have examined the impact of SDF on natural or using assisted reproductive techniques using various tests of DNA fragmentation (Evenson et al., 1999; Sergerie et al., 2005; Aitken and Koppers, 2011; Simon & Lewis, 2011; Ribas-Maynou et al., 2013) .
DNA fragmentation can be caused by a variety of factors such as infection, chemotherapy, radiotherapy, smoking, drug use, or advanced age (Fraga et al., 1996; Moskovtsev et al., 2006; Sergerie et al., 2007) . One of the major contributors of DNA fragmentation is increased levels of reactive oxygen species and oxidative stress.
The most commonly used methods for measuring sperm chromatin integrity include the sperm chromatin structure assay (SCSA) where sperm DNA breaks are evaluated by flow cytometry after heat or acid denaturation and staining with acridine orange. It measures all existing single-strand and double-strand DNA breaks including those with 3-OH breaks (Evenson et al., 2002; Virro et al., 2004; Bungum et al., 2007; Ribas-Maynou et al., 2013; Evenson, 2016) . Other commonly used tests include the Comet assay (single-cell gel electrophoresis), which evaluates DNA breaks in spermatozoa by the DNA migration in comet tails after electrophoresis (Lewis et al., 2013; Ribas-Maynou et al., 2013) , SCD (sperm chromatin dispersion) assay, which detects the characteristic halo of dispersed DNA loops in normal spermatozoa without DNA damage (Fernandez et al., 2011; Ribas-Maynou et al., 2013; Feijo & Esteves, 2014) and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay which quantifies the incorporation of fluoresceinated dUTP into single-and double-strand DNA breaks that contain free 3 0 OH extremities by labeling only the 3 0 -OH terminal with
TdT (Larson et al., 2000; Sergerie et al., 2005; Sharma et al., 2010 Sharma et al., , 2016 Ribas-Maynou et al., 2013; Cui et al., 2015; Muratori et al., 2015; Agarwal et al., 2016a,b) . All of these techniques vary in their diagnostic cut-off, accuracy (sensitivity, specificity) and their clinical utility (Larson et al., 2000; Boe-Hansen et al., 2005; Benchaib et al., 2007; Simon et al., 2011a,b; Cui et al., 2015) as they may determine different aspects of sperm DNA (Fraga et al., 1996; Agarwal et al., 2003 Agarwal et al., , 2014 Henkel et al., 2003 Henkel et al., , 2010 Borini et al., 2006; Moskovtsev et al., 2006; Muratori et al., 2006; Sergerie et al., 2007; Evenson & Wixon, 2008; Mahfouz et al., 2010; Aitken et al., 2010; Lewis et al., 2013) . Moreover, diagnostic accuracy of SDF for infertility based on these tests is not completely validated and studies have resulted in conflicting results (Cui et al., 2015; Osman et al., 2015) .
While SCSA continues to remain the gold standard among the several tests available for identifying clinically significant SDF, TUNEL assay continues to be extensively used. One of the challenges with the SDF results is the inconsistency and the large variability in the results obtained by different techniques and laboratories with different predictive power and clinical implications. A modified TUNEL assay combining DNA integrity and vitality was introduced by Mitchell et al. (2011) that further improved the robust nature of the TUNEL assay. While the TUNEL assay using flow cytometry is gaining popularity and becoming more common, there are inherent challenges in terms of thresholds and reproducibility among the different laboratories.
In our earlier study we have standardized the TUNEL assay and established reference ranges for SDF for healthy donors and infertile men . The second study from our group established the standardization of the bench top flow cytometer and provided a detailed TUNEL/PI protocol to serve as a reference protocol for laboratories offering TUNEL for SDF (Agarwal et al., 2016a,b; Sharma et al., 2016) .
We conducted this study to create a wider acceptance of establishing TUNEL in evaluation of SDF as a robust, precise and reproducible test when conducted under standardized assay conditions. Our goal was to standardize the TUNEL protocol and validate the results by two independent laboratories. This was accomplished by independently analyzing the same set of semen samples by two experienced observers in both clinical laboratories who utilized identical (i) TUNEL protocol, (ii) assay kit and (iii) acquisition settings with the same make and model of flow cytometer.
MATERIALS AND METHODS
This collaborative study was performed following institutional approval from the Clinic of Gynecological Endocrinology and Reproductive Medicine, University Hospital, Basel, Switzerland and the American Center for Reproductive Medicine, Cleveland Clinic, Cleveland, OH, USA. Semen samples were obtained from 31 subjects both donors and infertile men undergoing conventional semen analysis for diagnostic purposes at the Basler and the Cleveland Clinic between October 2015 and March 2016. Semen samples were collected by masturbation after 2-5 days of sexual abstinence.
Collection and evaluation of semen samples
Semen samples were collected into wide-mouth sterile plastic containers and allowed to liquefy at 37°C for 20 min. Semen analysis was carried out according to WHO-guidelines (World Health Organization, 2010 ) and the samples were examined for sperm concentration, sperm morphology and motility. Following initial semen analysis, sample aliquots were prepared for shipment and subsequent processing for measurement of SDF as described below.
Inter-laboratory exchange of samples
Three subsequent sets of experiments were performed. The first and the third set included 10 freshly collected semen samples, which were evaluated in Basel. Aliquots were prepared for assessment of DNA fragmentation and shipped to Cleveland. For the second set, 11 semen samples were collected fresh and evaluated in Cleveland. Similarly aliquots were prepared for DNA fragmentation assessment and shipped to Basel on dry ice. In the laboratory responsible for sample collection, hereafter called 'reference laboratory', at each sample collection, four aliquots of each sample were prepared for shipment to the 'test laboratory'. These consisted of two aliquots of 'Test sample', one aliquot of 'Negative control' and one 'Positive control'. DNA damage was chemically induced in the Positive control sample by hydrogen peroxide.
Preparation of semen samples for shipment
Following semen analysis, aliquots containing 4 9 10 6 spermatozoa were pipetted into 5 mL polystyrene round bottom tubes (Corning, Tamaulipas, Mexico) and centrifuged for 7 min at 400 g. Seminal plasma was carefully aspirated and discarded. The 'Test' and 'Negative Controls' were fixed by resuspension into 1 mL of 3.7% paraformaldehyde (PFA) (Thermo Scientific, Rockford, IL, USA) and kept overnight at 4°C. The following day, the samples were centrifuged for 7 min at 400 g, the PFA
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was carefully removed and the spermatozoa were re-suspended into 1 mL ice-cold ethanol (70% vol./vol.). The samples were kept at À20°C until shipped on dry ice or analyzed.
Preparation of positive controls
Sperm DNA fragmentation was chemically induced in the 'Positive control' samples. Prior to fixation, 1 mL of hydrogen peroxide (2%) was added to the 'Positive control' and the aliquot was incubated for 1 h at 50°C. The samples were then centrifuged for 7 min at 400 g to remove the hydrogen peroxide solution; they were either directly re-suspended into 3.7% PFA or washed once with PBS 19, re-suspended in 3.7% PFA and kept overnight at 4°C. Samples were centrifuged the next day to remove PFA and then re-suspended in ice-cold ethanol and kept at À20°C until shipped or analyzed. On the day of the shipment, ethanol fixed samples were transferred to 1.8 mL cryovials and shipped on dry ice.
Measurement of SDF
Both laboratories analyzed the same set of semen samples using the Apo-Direct kit from BD Pharmingen (BD Biosciences, San Diego, CA, USA) according to the manufacturer instructions and protocols developed specifically for the analysis of human spermatozoa by the TUNEL/PI test (Sharma et al., , 2016 . In the second and third set of experiments, the identical apoptosis kits (same kit lot number) were used in both laboratories. Together with the semen samples, 2 mL aliquots of 'Positive control' and 'Negative control' provided with the kit were also included with each batch analysis. Ethanol was removed by centrifugation at 400 g for 7 min, and the samples were washed twice with 1 mL of the 'Wash Buffer' provided in the apoptosis kit. DNA labeling solution containing deoxynucleotidyl transferase (TdT) reaction buffer, TdT enzyme and fluorescein-dUTP (FITC-dUTP) was prepared, and 50 lL were added to the 'Test control' and the 'Positive control'. For each semen sample, a 'Negative control' containing all the components of the labeling solution except the TdT enzyme and one 'Positive control' was included. After labeling, the samples were washed twice with 1 mL of 'Rinsing buffer' and incubated in 500 lL of propidium iodide (PI)/RNase for 30 min in the dark. Flow cytometry analysis was performed within 1 h of the PI/RNase staining.
Acquisition of TUNEL/PI data
Samples were analyzed for SDF by TUNEL/PI assay with a BD ACCURI C6 flow cytometer (BD Biosciences). Before analysis, the performance of the Accuri instrument was validated with 8-peak validation beads (FL1-FL4) (Spherotech beads; BD Biosciences). Data were acquired using the 'Slow' fluidics speed. The run limit was set to 10,000 events gated in the PI channel (FL2) and the threshold was set to 80,000 on FSC-H. TUNELpositive cells were identified as PI-positive (FL2-channel, 585/ 40 nm filter) and fluorescein-positive cells (FL1-channel, 533/ 30 nm filter).
Analysis of TUNEL/PI data
In the first set of experiments, each laboratory used its own ACCURI C6 Workspace for TUNEL analysis. For re-analysis of the first set of experiments and for the second and third rounds, a common 'Workspace' was created and used by both laboratories. The ACCURI C6 workspace for inter-laboratory TUNEL assay was established using three plots and a sequential gating strategy (Fig. 1) . 1 Plot 'a' (forward scatter-FSC/side scatter-SSC): In this plot, a gate was drawn to select spermatozoa with the expected size (G1) and to exclude small debris, and larger non-spermatozoa and seminal cells 2 Plot 'b' (PI fluorescence/FSC): Within the cells belonging to G1, spermatozoa were further identified in the second plot by gating the PI-positive events (G2). This allowed the exclusion of debris and M540-apoptotic bodies lacking chromatin (Marchiani et al., 2007) . 3 Plot 'c' (PI fluorescence/FITC fluorescence): Within the cells included in gates 'G2' and 'G1', the TUNEL-positive spermatozoa were identified and denoted as the percentage of spermatozoa that were simultaneously positive for PI and FITC. Plot 'c' relates to the 'Negative control' sample where TdT was omitted. 4 Plot 'd' relates to the stained 'Test sample' for examination of SDF. 5 Plot 'e' refers to the 'Positive control' sample with induced SDF.
In the example shown in Fig. 1 , the sample contains 20.5% TUNEL-positive spermatozoa, whereas the positive control contains 36.8% TUNEL-positive spermatozoa.
The ACCURI C6 software (BD Biosciences, Ann Arbor, MI, USA) creates quadrants for dot plots data analysis. To simplify the analysis, the two lower quadrants were set to have no spermatozoa. TUNEL/PI-positive samples were thus identified as the percentage of spermatozoa within the Upper right quadrant (Q1-UR) as shown in Fig. 1C-E) .
For the development of a standardized TUNEL method it was important to reposition the cells in the 'Analysis dot plots' or histograms. Because the ACCURI C6 instrument has no volts or amp gain controls, the 'Virtual Gain' ACCURI C6 software module was used to adjust and align the semen samples according to the experimental setting.
Standardization of TUNEL assay
A common 'Workspace' was used by both laboratories and an Accuri 'Acquisition file' of one semen sample was selected by the reference laboratory as a 'standard acquisition file' (SAF) and sent to the test laboratory. Following this, all samples were aligned with this SAF and the 'Virtual Gain' module, and the results were again compared. The negative peak of the spermatozoa population in a histogram displaying FL1 fluorescence was used as the reference for alignment. In the second and third set of experiments, the reference laboratory sent the ACCURI C6 SAF, a tube containing the 'Standard sample' to be analyzed in the test laboratory and the information of the percentage of TUNEL/PI-positive samples obtained with the 'Standard sample'. In the test laboratory, the 'Standard sample' was included and stained together with the samples prepared for TUNEL assay. After acquisition, the SAF was used to align all the samples and the acquisition plot of the 'Standard sample' was used to set the quadrant gates to obtain the TUNELpositive percentage indicated by the 'reference laboratory'. These gates were then used in the analysis of all samples run in the same batch and the TUNEL-positivity obtained for each sample. The TUNEL results obtained in both laboratories were then compared.
Statistical analysis
After testing for normal distribution using Kolmogorov-Smirnov test, Spearman's Rank correlation was used to determine the strength of the relationship between the TUNEL values obtained in each laboratory. Evans' classification was used to categorize the degree of correlation as: moderate; r = 0.40-0.59; strong; r = 0.60-0.79 and very strong: r ≥ 0.80 (Evans, 1996) . In addition, average SDF rates were evaluated using Wilcoxon Signed Rank Test, the level of statistical significance was set at 0.05.
RESULTS

Consistency of TUNEL analysis within a single laboratory
The results of duplicate measurements of semen samples within each laboratory demonstrate that the average difference between duplicate readings was 0.5% (0.1-5.7%). The correlation between the duplicate readings was high or very high (r = 0.75-0.95) (Table 1, Fig. 1 ). No significant differences were observed between the duplicates in any of the experiments performed. These results demonstrate that the transit time during the shipment did not affect the samples. Consistency of the TUNEL assay and performance of ACCURI C6 Before each run, both laboratories validated the performance of each ACCURI C6 flow cytometer using 8-peak validation beads with the same lot number. The difference in the fluorescence intensity of the highest peak for FL1 (FITC fluorescence) and FL2 (PI fluorescence) was <3.5% between the two instruments. Both instruments performed within the established normal limits set by the manufacturer, which showed that both cytometers were identical in their performance.
Consistency of TUNEL analysis between laboratories
First set of experiments
Although experienced operators analyzed the flow cytometry results of the same set of semen samples in both laboratories using the same assay kit, test protocol and bench flow cytometers with identical performance, the comparison between values obtained in the first set of experiments showed that there were considerable differences between the TUNEL results obtained in different laboratories (p < 0.05) (Fig. 2, Tables 1 and S1 ). The differences between the sample measurements ranged from 2.6 to 13.9%. These discrepancies were even more striking when the samples with higher percentages of DNA damage were compared, with values ranging from 6.9 to 30.2%. Even though one laboratory measured higher levels of DNA fragmentation, the results in both laboratories were still correlated (r = 0.6, p = 0.06). The percentage of TUNEL-positive control cells in the assay kit provided by manufacturer differed by <3% between the two laboratories, indicating that the observed differences in the TUNEL results seen in the semen samples were not attributed to differences in the staining and/or assay technique.
For that reason, both the 8-peak beads and the 'Negative' and 'Positive' controls provided by the vendor were not used for further standardization of the TUNEL settings. Instead, a semen sample acquisition file was used to align all the semen samples in each laboratory. After adopting this strategy and aligning all samples with the SAF, the correlation of the results increased significantly (r > 0.80). However, the mean TUNEL values obtained in the reference laboratory were still significantly higher than those obtained in the test laboratory (p < 0.05). Figure 2 Examples of TUNEL correlation plots comparing the percentages of TUNEL positivity obtained in each set of experiments (Sets 1-3) within each laboratory (reference laboratory: plots R/R and test laboratory: plots T/T) or between laboratories (R/T or T/R). In the plots where laboratories are compared, the type of alignment used in the data analysis is indicated as: no alignment; SAF-alignment with standard acquisition file; SAF and SS-alignment with standard acquisition file and standard sample. Plots comparing only positive controls (Pos. controls) are also shown. R = reference laboratory; T = test laboratory; r = Spearman's Rank correlation coefficient; p = Wilcoxon Signed Rank Test p value.
Second set of experiments
For the second set of experiments, a standard sample (SS) with a known level of DNA fragmentation was sent to the test laboratory. This sample was used to set the ACCURI C6 analysis gates to obtain identical percentage of SDF as obtained by the standard laboratory. This SS was sent together with additional semen samples with unknown levels of SDF. Unfortunately, during shipment there was a loss of fluid from the cryovials. In some tubes, more than 50% of the original volume was lost. Despite this, the alignment strategy allowed us to obtain a strong or very strong correlation of the results (r > 0.60) (Table 1, Fig. 2) . We achieved a similar percentage of average SDF in both laboratories ranging between 0.6 and 6.9% (Table S1 ). However, although the correlation between the 'Positive control' samples was high (r = 0.825), the control results showed significant variation between the two laboratories (p = 0.001). Compared with the reference laboratory, the test laboratory still continued to obtain higher DNA fragmentation rates in the 'Positive controls' than the reference laboratory.
Third set of experiments
In the third set of experiments, we followed the same strategy as in the second set, but because of the higher variability in the results observed in the measurements of SDF in the 'Positive controls', we introduced an additional washing step. The results (Table 1, Fig. 2) showed that this strategy considerably improved the results of the 'Positive Controls' with high levels of SDF. Furthermore, the results between the laboratories showed a very high correlation (r = 0.94) for 'Positive controls', and the mean values were very similar. No significant sample loss was observed during shipment. The differences in the average SDF values obtained for each laboratory ranged from 0.2 to 5.2% (Table S1 ). There was one outlier that showed a difference of 9.8%. A strong correlation was observed between the average SDF rates (r = 0.719) and the mean SDF rates measured in each laboratory, and these results were similar (Table 1) .
DISCUSSION
The extent of SDF in spermatozoa is a valuable biomarker for evaluating male factor infertility. It reflects the integrity of the genetic material of the spermatozoa. Sperm DNA integrity is a good predictor of semen quality because of its ability to discriminate fertile individuals from the infertile ones (Sergerie et al., 2005; Sharma et al., 2010 Sharma et al., , 2016 Ribas-Maynou et al., 2013; Feijo & Esteves, 2014) . With the exception of the SCSA, all the currently available techniques for evaluating sperm DNA integrity vary in their diagnostic accuracy and clinical value. Furthermore, the main challenge of these advanced tests is the lack of reproducibility and lack of established reference values.
With this in mind, we aimed to establish the reproducibility between two reference laboratories across two different continents utilizing a standardized protocol by two experienced personnel conducting the test. Semen samples were processed from the same subjects. Furthermore, the same TUNEL assay kit was used to measure SDF by TUNEL/PI using an identical bench flow cytometer. In our earlier study, we published a step by step protocol for conducting the TUNEL test using the apoptosis detection kit and the bench flow cytometer (ACCURI C6; Agarwal et al., 2016a,b) . We established the reference values, the sensitivity and specificity, the negative and positive predictive values as well as the area under the curve for SDF using a receiver operating characteristic curve (Sharma et al., 2016) .
To describe the intra-laboratory variability, we determined each individual measurement and its extent of difference from the designated measurement. The intra-laboratory correlation coefficients were moderate to high for all three sets of cohorts and for the cohort 2 and 3 combined (Table 1, Fig. 2) . The results of the duplicate measurements of SDF indicated low percent differences, which were not significant and reflected low variability in the TUNEL assessment for the same sample within both the reference and the testing laboratories. The results of low intra-laboratory variability established the reproducibility of the assay.
Our protocol combines the nuclear staining with PI for detecting SDF as described by Marchiani et al. (2014) . The inclusion of the PI stain is an important step as it allows the identification and exclusion of the semen apoptotic bodies, termed as M540 bodies. These bodies are similar in size and density to abnormal apoptotic spermatozoa (Marchiani et al., 2007) . Their inclusion in TUNEL analysis results in underestimation of SDF as seen in most semen samples (Marchiani et al., 2014) . Although the inclusion of PI yields more precise, standardized and accurate measurement than the simple TUNEL test (Muratori et al., 2008) , significant differences between the two laboratories were still observed. The first cohort of samples which were run with no alignment strategy showed only moderate correlation between the laboratories for the test samples and the positive controls. Higher SDF was always assessed by the reference laboratory. Only with the introduction of a common ACCURI C6 analysis Workspace and the inclusion of a SAF for samples alignment, the correlation of results between the two laboratories was enhanced. This showed the importance of data analysis in the standardization of TUNEL assay.
The common ACCURI C6 Workspace guarantees that the same gating strategy is followed by the different laboratories and identical spermatozoa populations are selected for SDF quantification (Fig. 1) . The alignment of the samples with a SAF corrects for shifts in the positioning of the cells and brings all spermatozoa into the same position in the dot plots. This step revealed to be essential to increase TUNEL results agreement between laboratories.
Hence the standardization efforts for the assay were further augmented by running a SS with a known amount of SDF and aligning all the samples with the SAF obtained from SS. The SS was sent from the reference laboratory and was included in the TUNEL run with other samples by the testing laboratory. The SSs were chosen to have a DNA damage between 5 and 15%. This step further corrects inter-operator differences in setting the final location of the quadrants (Fig. 1) allowing the test laboratory to position them in agreement with the TUNEL-positivity percentage indicated by the reference laboratory.
The introduction of a SS together with the SAF alignment strategy allowed us to obtain a strong or very strong correlation of the results (Spearman's r > 0.6) ( Fig. 2 and Table 1 ) and the laboratories succeeded in achieving similar average DNA fragmentation values, the differences ranging between 0.6 and 6.9% (Set 2) and 0.2 and 5.2% (Set 3). The larger differences obtained for positive controls (Fig. 2, Set 2) were eliminated by adding one extra washing step after the chemical induction of DNA damage by hydrogen peroxide. A residual amount of this reagent 482 Andrology, 2017, 5, 477-485 © 2017 American Society of Andrology and European Academy of Andrology left in the samples might have caused extra damage to DNA during shipment and storage, leading to a higher TUNEL percentage obtained in the Test laboratory. The final low inter-laboratory and intra-individual variability in SDF reported by TUNEL/PI in our results suggests the clinical usefulness of the test in the workup of male infertility in an andrology laboratory. In our internal validation of the TUNEL protocol we tested the same semen sample over time using kits with distinct lot numbers and obtained very low coefficients of variation, so we believe that the lot number may not be a detriment in standardization of the test. However, as this inter-laboratorial standardization involved a great deal of time and cost between the two testing laboratories we decided not to introduce another variable at this time, therefore the second and third set of experiments were performed with the same lot number.
In conclusion, we have, for the first time, established a standardized terminal deoxynucleotidyl transferase dUTP nick end labeling/propidium iodide protocol across laboratories, which involves the use of identical ACCURI C6 flow cytometer, a common workspace designed for data acquisition and analysis of the data after alignment with a standard sample. The bench top comes with easy-to-use software tools, which allow precise control when setting gates and standardizing the acquisition strategies. Although our work refers to standardization only between ACCURI C6 cytometers we believe that other bench flow cytometers can be used provided that their performances are similar to ACCURI C6 and the software tools allow the access to the standard acquisition file and alignment of the test samples with the standard. As for the cytometry based sperm chromatin structure assay test, which has already been proved to be repeatable in different laboratories and with different flow cytometers (Evenson et al., 1995; Evenson, 2011) , we believe that our work provides evidence that the same can be accomplished for the terminal deoxynucleotidyl transferase dUTP nick end labeling test. We propose similar multicenter trials with standardized terminal deoxynucleotidyl transferase dUTP nick end labeling/propidium iodide assessment to further validate the robust reproducibility of the results with minimal variability. This will help establish useful reference ranges and improve the predictive value of terminal deoxynucleotidyl transferase dUTP nick end labeling/propidium iodide in natural and in vitro fertilization/intracytoplasmic sperm injection success rates.
